Insider filing · BGNE

Lai Wang sold $1.3M of BeiGene (BGNE)

Executed Feb 21 2025, disclosed Feb 25 2025, 4 days later.

Returns are measured on stock purchases only.

LW Lai Wang President, Global Head of R&D profile →

Lai Wang (President, Global Head of R&D) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $357K of ONC (1,327 sh × $269.34, as filed), executed Jun 8.

BGNE BGNE BGNE · 23 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→